RxDoctor Payments Data

Kayla Linville, APRN

Nurse Practitioner · Maysville, KYNPI 1649781691

Payments from drug & device makers

$2,406in general payments, 2019–2025

Across 107 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$627
  • Johnson & Johnson$204
  • Sumitomo Pharma America, Inc.$181
  • Grifols USA, LLC$140
  • Otsuka America Pharmaceutical, Inc.$128
  • Antares Pharma, Inc.$118
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$1,93480%
  • Education$47220%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,406 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,209
Medicare patients
118
Services billed
297

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron193$144,712
MyrbetriqMirabegron121$89,008
XyostedTestosterone Enanthate99$60,238
PremarinEstrogens, Conjugated34$14,872
Fosfomycin Tromethamine40$14,864
Methenamine Hippurate41$3,237
Testosterone Cypionate106$2,222
Tamsulosin Hcl233$1,949
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst56$1,186
Finasteride141$1,048
Dutasteride22$740
Estradiol13$699
Trimethoprim16$694
CefuroximeCefuroxime Axetil31$643
Oxybutynin Chloride ErOxybutynin Chloride27$524

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$181$144,712193 claims
Astellas Pharma US IncMyrbetriq$627$89,008121 claims
Antares Pharma, Inc.Xyosted$118$60,23899 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Maysville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →